Skip to content

Clinical trials

Phase 2 Hepatitis B, Chronic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 2 Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20131
20142
20151
20171
20192
20201
20211
20223
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
GlaxoSmithKline4
Janssen Sciences Ireland UC2
ANRS, Emerging Infectious Diseases1
Aligos Therapeutics1
AusperBio Therapeutics Inc.1
Hoffmann-La Roche1
Instituto Grifols, S.A.1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic17
Hepatitis B9
Hepatitis3
Liver Diseases2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1
Disease Attributes1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.